Global Hospital Infection Therapeutics Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 2016 | Number of pages: 199 | Publish Date: Jan 2020 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New

Latest research report on Hospital Infection Therapeutics Market delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrates its growth trends and competitive landscape as well as the key players in the business.

Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.

The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.

North America led the demand for hospital infection therapeutics market in 2017. The high prevalence of nosocomial infections has been identified as the key factor that has been driving the demand for infection therapeutics in North America and is projected to continue to do so throughout the forecast period. Although North America will remain the leading regional market for hospital infection therapeutics, it is Asia Pacific, which will present the most promising growth opportunities to this market in the near future.

In 2018, the global Hospital Infection Therapeutics market size was 2700 million US$ and it is expected to reach 3840 million US$ by the end of 2025, with a CAGR of 4.5% during 2019-2025.

This report focuses on the global Hospital Infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital Infection Therapeutics development in United States, Europe and China.

The key players covered in this study
    Bayer
    Johnson & Johnson Services
    Actavis
    Sanofi
    Bristol Myers Squibb Company
    AstraZeneca
    Pfizer
    Merck
    GlaxoSmithkline
    Cubist Pharmaceuticals

Market segment by Type, the product can be split into
    Antibacterial Drugs
    Antiviral Drugs
    Antifungal Drugs

Market segment by Application, split into
    Hospital Acquired Pneumonia
    Surgical Site Infections
    Urinary Tract Infection
    Gastrointestinal Disorders
    Bloodstream Infections
    Others

In this study, the years considered to estimate the market size of Hospital Infection Therapeutics are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Hospital Infection Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Hospital Infection Therapeutics development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.


For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Hospital Infection Therapeutics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Hospital Infection Therapeutics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Hospital Infection Therapeutics Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Hospital Infection Therapeutics Market Overview: Quantitative Analysis
3.1. Global Hospital Infection Therapeutics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Hospital Infection Therapeutics Market Revenue Market Share (%), 2014- 2025
3.3. Global Hospital Infection Therapeutics Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Hospital Infection Therapeutics Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Hospital Infection Therapeutics Market Analysis: Segmentation By Type
5. Chapter – Global Hospital Infection Therapeutics Market Analysis: Segmentation By Application
6. Chapter - Global Hospital Infection Therapeutics Market Analysis: By Manufacturer 
6.1. Global Hospital Infection Therapeutics Market Revenue (USD Million), by Manufacturer, 2014 - 2025
6.2. Global Hospital Infection Therapeutics Market Share (%), by Manufacturer, 2018
6.3. Global Hospital Infection Therapeutics Market Sales (Number of Units), by Manufacturer, 2014 - 2025
6.4. Global Hospital Infection Therapeutics Market Share (%), by Manufacturer, 2018
6.5. Global Hospital Infection Therapeutics Market Price (USD/Unit), by Manufacturer, 2014 - 2025
6.6. Global Hospital Infection Therapeutics Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter –Hospital Infection Therapeutics Market: Regional Analysis
7.1. North America
7.1.1. North America Hospital Infection Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
7.1.2. North America Hospital Infection Therapeutics Market Revenue (USD Million) By Country, 2014 – 2025.
7.1.3. North America Hospital Infection Therapeutics Revenue Market Share (%) By Country, 2014 – 2025.
7.1.4. North America Hospital Infection Therapeutics Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.5. North America Hospital Infection Therapeutics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.6. North America Hospital Infection Therapeutics Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
7.1.7. North America Hospital Infection Therapeutics Market Sales (Number of Units) By Country, 2014 – 2025.
7.1.8. North America Hospital Infection Therapeutics Sales Market Share (%) By Country, 2014 – 2025.
7.1.9. North America Hospital Infection Therapeutics Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.10. North America Hospital Infection Therapeutics Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.